Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Hegde A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Ng T, Otterson GA, Patel SP, Patil T, Polanco PM, Riely GJ, Riess J, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory KM, Hughes M. Ettinger DS, et al. Among authors: massarelli e. J Natl Compr Canc Netw. 2023 Apr;21(4):340-350. doi: 10.6004/jnccn.2023.0020. J Natl Compr Canc Netw. 2023. PMID: 37015337
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer.
De Laurentiis M, Arpino G, Massarelli E, Ruggiero A, Carlomagno C, Ciardiello F, Tortora G, D'Agostino D, Caputo F, Cancello G, Montagna E, Malorni L, Zinno L, Lauria R, Bianco AR, De Placido S. De Laurentiis M, et al. Among authors: massarelli e. Clin Cancer Res. 2005 Jul 1;11(13):4741-8. doi: 10.1158/1078-0432.CCR-04-2569. Clin Cancer Res. 2005. PMID: 16000569 Free article.
An Analysis and Comparison of Survival and Functional Outcomes in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Concurrent Chemoradiation Therapy within City of Hope Cancer Center Sites.
Pharaon R, Chung S, Amini A, Maghami E, Chowdhury A, Vora N, Chang S, Kang R, Gernon T, Hansen K, Kelly C, Ackerman D, Vora L, Sampath S, Massarelli E. Pharaon R, et al. Among authors: massarelli e. J Clin Med. 2020 Sep 24;9(10):3083. doi: 10.3390/jcm9103083. J Clin Med. 2020. PMID: 32987866 Free PMC article.
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients.
Roosan MR, Mambetsariev I, Pharaon R, Fricke J, Baroz AR, Chao J, Chen C, Nasser MW, Chirravuri-Venkata R, Jain M, Smith L, Yost SE, Reckamp KL, Pillai R, Arvanitis L, Afkhami M, Wang EW, Chung V, Cristea M, Fakih M, Koczywas M, Massarelli E, Mortimer J, Yuan Y, Batra SK, Pal S, Salgia R. Roosan MR, et al. Among authors: massarelli e. Cancers (Basel). 2021 Jun 3;13(11):2776. doi: 10.3390/cancers13112776. Cancers (Basel). 2021. PMID: 34204917 Free PMC article.
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
Carlomagno C, Lauria R, De Laurentiis M, Arpino G, Massarelli E, Ferrara C, Milano A, Vernaglia Lombardi A, Costanzo R, Catalano G, Bianco AR, De Placido S. Carlomagno C, et al. Among authors: massarelli e. Oncology. 2002;63(3):219-25. doi: 10.1159/000065468. Oncology. 2002. PMID: 12381900 Clinical Trial.
Erratum: A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer.
Mohanty A, Nam A, Pozhitkov A, Yang L, Srivastava S, Nathan A, Wu X, Mambetsariev I, Nelson M, Subbalakshmi AR, Guo L, Arvanitis LD, Nasser MW, Batra SK, Orban J, Jolly MK, Massarelli E, Kulkarni P, Salgia R. Mohanty A, et al. Among authors: massarelli e. iScience. 2020 Oct 23;23(11):101679. doi: 10.1016/j.isci.2020.101679. eCollection 2020 Nov 20. iScience. 2020. PMID: 33134900 Free PMC article.
ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response.
Sousa LG, Rajapakshe K, Rodriguez Canales J, Chin RL, Feng L, Wang Q, Barrese TZ, Massarelli E, William W, Johnson FM, Ferrarotto R, Wistuba I, Coarfa C, Lee J, Wang J, Melief CJM, Curran MA, Glisson BS. Sousa LG, et al. Among authors: massarelli e. J Immunother Cancer. 2022 Feb;10(2):e004232. doi: 10.1136/jitc-2021-004232. J Immunother Cancer. 2022. PMID: 35193933 Free PMC article. Clinical Trial.
111 results